Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphoprotein phosphatase activity	DUSP28 ACP2 ACP3 PTK2 PTPRD PTPRF SBF1 PTPRN2 PTPRQ DUSP8 PPEF2 CTDNEP1 PTPN5	2.17e-07	189	223	13	GO:0004721
GeneOntologyMolecularFunction	protein tyrosine phosphatase activity	DUSP28 ACP3 PTK2 PTPRD PTPRF PTPRN2 PTPRQ DUSP8 PTPN5	2.32e-06	103	223	9	GO:0004725
GeneOntologyMolecularFunction	phosphatase activity	DUSP28 PNKP ACP2 ACP3 PTK2 PTPRD PTPRF SBF1 PTPRN2 PTPRQ DUSP8 PPEF2 CTDNEP1 PTPN5	4.55e-06	287	223	14	GO:0016791
GeneOntologyMolecularFunction	phosphoric ester hydrolase activity	DUSP28 PNKP ACP2 ACP3 PTK2 PTPRD PTPRF SBF1 PTPRN2 PTPRQ DUSP8 SMPD4 PPEF2 CTDNEP1 PTPN5	3.11e-05	386	223	15	GO:0042578
GeneOntologyMolecularFunction	hydrolase activity, acting on ester bonds	DUSP28 PNKP AZGP1 ACP2 ACP3 PTK2 PTPRD PTPRF SBF1 PTPRN2 PTPRQ DUSP8 SMPD4 VARS2 PPEF2 CTDNEP1 PNPLA5 PLBD2 PTPN5 SND1 DROSHA	2.94e-04	807	223	21	GO:0016788
GeneOntologyBiologicalProcess	protein dephosphorylation	DUSP28 PTPRD PTPRF SBF1 PTPRN2 PTPRQ LILRA2 RCAN1 DUSP8 PPEF2 CTDNEP1 PTPN5	2.19e-05	256	221	12	GO:0006470
GeneOntologyBiologicalProcess	dephosphorylation	DUSP28 ACP2 ACP3 PTPRD PTPRF SBF1 PTPRN2 PTPRQ LILRA2 RCAN1 DUSP8 PPEF2 CTDNEP1 PTPN5	2.44e-05	347	221	14	GO:0016311
Domain	IGc2	CHL1 SPEG DSCAML1 LRIG2 IGSF10 HMCN2 PTPRD PTPRF ROBO3 FLT1 LILRA2 MXRA5 ROR1 LRIG3 HMCN1 LRIG1 IGSF1 MYBPC2	3.29e-10	235	218	18	SM00408
Domain	Ig_sub2	CHL1 SPEG DSCAML1 LRIG2 IGSF10 HMCN2 PTPRD PTPRF ROBO3 FLT1 LILRA2 MXRA5 ROR1 LRIG3 HMCN1 LRIG1 IGSF1 MYBPC2	3.29e-10	235	218	18	IPR003598
Domain	Ig_I-set	CHL1 SPEG DSCAML1 LRIG2 IGSF10 HMCN2 PTPRD PTPRF ROBO3 FLT1 MXRA5 ROR1 LRIG3 HMCN1 LRIG1 MYBPC2	8.22e-10	190	218	16	IPR013098
Domain	I-set	CHL1 SPEG DSCAML1 LRIG2 IGSF10 HMCN2 PTPRD PTPRF ROBO3 FLT1 MXRA5 ROR1 LRIG3 HMCN1 LRIG1 MYBPC2	8.22e-10	190	218	16	PF07679
Domain	Ig-like_dom	CHL1 PTCRA HLA-DQB1 SPEG AZGP1 DSCAML1 LRIG2 IGSF10 HMCN2 PTPRD PTPRF ROBO3 KIR3DL1 KIR3DS1 FLT1 LILRA2 MXRA5 ROR1 NECTIN3 LRIG3 HMCN1 LRIG1 IGSF1 FCAMR MYBPC2	1.14e-09	503	218	25	IPR007110
Domain	Ig-like_fold	CHL1 PTCRA HLA-DQB1 SPEG AZGP1 DSCAML1 LRIG2 IGSF10 HMCN2 PTPRD PTPRF ROBO3 KIR3DL1 KIR3DS1 PLXNA3 FLT1 LILRA2 MXRA5 ROR1 FNDC3A NECTIN3 LRIG3 HMCN1 LRIG1 IGSF1 IL3RA FCAMR PRLR MYBPC2	3.91e-09	706	218	29	IPR013783
Domain	-	CHL1 PTCRA HLA-DQB1 SPEG AZGP1 DSCAML1 LRIG2 IGSF10 PTPRD PTPRF ROBO3 KIR3DL1 KIR3DS1 PLXNA3 FLT1 LILRA2 MXRA5 ROR1 FNDC3A NECTIN3 LRIG3 HMCN1 LRIG1 IGSF1 IL3RA FCAMR PRLR MYBPC2	4.07e-09	663	218	28	2.60.40.10
Domain	IG	CHL1 SPEG DSCAML1 LRIG2 IGSF10 HMCN2 PTPRD PTPRF ROBO3 KIR3DL1 KIR3DS1 FLT1 LILRA2 MXRA5 ROR1 NECTIN3 LRIG3 HMCN1 LRIG1 IGSF1 FCAMR MYBPC2	4.86e-09	421	218	22	SM00409
Domain	Ig_sub	CHL1 SPEG DSCAML1 LRIG2 IGSF10 HMCN2 PTPRD PTPRF ROBO3 KIR3DL1 KIR3DS1 FLT1 LILRA2 MXRA5 ROR1 NECTIN3 LRIG3 HMCN1 LRIG1 IGSF1 FCAMR MYBPC2	4.86e-09	421	218	22	IPR003599
Domain	IG_LIKE	CHL1 HLA-DQB1 SPEG AZGP1 DSCAML1 LRIG2 IGSF10 HMCN2 PTPRD PTPRF ROBO3 KIR3DL1 FLT1 LILRA2 MXRA5 ROR1 NECTIN3 LRIG3 HMCN1 LRIG1 IGSF1 FCAMR MYBPC2	1.67e-08	491	218	23	PS50835
Domain	Prot-tyrosine_phosphatase-like	DUSP28 PTPRD PTPRF SBF1 PTPRN2 DUSP8 PTPN5 SBF2	2.09e-05	99	218	8	IPR029021
Domain	TYR_PHOSPHATASE_dom	DUSP28 PTPRD PTPRF SBF1 PTPRN2 DUSP8 PTPN5	7.10e-05	87	218	7	IPR000387
Domain	ig	CHL1 DSCAML1 LRIG2 PTPRD KIR3DL1 KIR3DS1 FLT1 LILRA2 HMCN1 IGSF1	8.17e-05	190	218	10	PF00047
Domain	Immunoglobulin	CHL1 DSCAML1 LRIG2 PTPRD KIR3DL1 KIR3DS1 FLT1 LILRA2 HMCN1 IGSF1	8.17e-05	190	218	10	IPR013151
Domain	fn3	CHL1 SPEG DSCAML1 PTPRD PTPRF ROBO3 FNDC3A PRLR MYBPC2	1.23e-04	162	218	9	PF00041
Domain	Med12	MED12L MED12	1.36e-04	2	218	2	PF09497
Domain	Mediator_Med12_catenin-bd	MED12L MED12	1.36e-04	2	218	2	IPR021989
Domain	Med12-PQL	MED12L MED12	1.36e-04	2	218	2	PF12144
Domain	Med12-LCEWAV	MED12L MED12	1.36e-04	2	218	2	PF12145
Domain	Med12	MED12L MED12	1.36e-04	2	218	2	SM01281
Domain	M_domain	TNRC6A TNRC6C	1.36e-04	2	218	2	PF12938
Domain	Mediator_Med12	MED12L MED12	1.36e-04	2	218	2	IPR019035
Domain	GW182_M_dom	TNRC6A TNRC6C	1.36e-04	2	218	2	IPR026805
Domain	Mediator_Med12_LCEWAV	MED12L MED12	1.36e-04	2	218	2	IPR021990
Domain	FN3_dom	CHL1 SPEG DSCAML1 PTPRD PTPRF ROBO3 FNDC3A IL3RA PRLR MYBPC2	1.79e-04	209	218	10	IPR003961
Domain	FN3	CHL1 SPEG DSCAML1 PTPRD PTPRF ROBO3 FNDC3A PRLR MYBPC2	3.33e-04	185	218	9	SM00060
Domain	Ago_hook	TNRC6A TNRC6C	4.04e-04	3	218	2	PF10427
Domain	DUF3523	ATAD3B ATAD3A	4.04e-04	3	218	2	IPR021911
Domain	SBF2	SBF1 SBF2	4.04e-04	3	218	2	PF12335
Domain	TNRC6_PABC-bd	TNRC6A TNRC6C	4.04e-04	3	218	2	IPR032226
Domain	Argonaute_hook_dom	TNRC6A TNRC6C	4.04e-04	3	218	2	IPR019486
Domain	DUF3523	ATAD3B ATAD3A	4.04e-04	3	218	2	PF12037
Domain	TNRC6-PABC_bdg	TNRC6A TNRC6C	4.04e-04	3	218	2	PF16608
Domain	SBF1/SBF2	SBF1 SBF2	4.04e-04	3	218	2	IPR022096
Domain	TYR_PHOSPHATASE_1	DUSP28 PTPRD PTPRF PTPRN2 DUSP8 PTPN5	5.10e-04	86	218	6	PS00383
Domain	TYR_PHOSPHATASE_2	DUSP28 PTPRD PTPRF PTPRN2 DUSP8 PTPN5	5.43e-04	87	218	6	PS50056
Domain	FN3	CHL1 SPEG DSCAML1 PTPRD PTPRF ROBO3 FNDC3A PRLR MYBPC2	5.65e-04	199	218	9	PS50853
Domain	-	DUSP28 PTPRD PTPRF PTPRN2 DUSP8 PTPN5	7.30e-04	92	218	6	3.90.190.10
Domain	PTPc	PTPRD PTPRF PTPRN2 PTPN5	7.94e-04	36	218	4	SM00194
Domain	G2F	HMCN2 HMCN1	8.01e-04	4	218	2	PF07474
Domain	Hox9_activation_N	HOXB9 HOXC9	8.01e-04	4	218	2	IPR006711
Domain	NIDOGEN_G2	HMCN2 HMCN1	8.01e-04	4	218	2	PS50993
Domain	GFP	HMCN2 HMCN1	8.01e-04	4	218	2	IPR009017
Domain	HXA9/HXB9/HXC9	HOXB9 HOXC9	8.01e-04	4	218	2	IPR017112
Domain	Hox9_act	HOXB9 HOXC9	8.01e-04	4	218	2	PF04617
Domain	G2_nidogen/fibulin_G2F	HMCN2 HMCN1	8.01e-04	4	218	2	IPR006605
Domain	PROTEIN_KINASE_TYR	ABL2 PTK2 SYK FLT1 ROR1 AATK	9.65e-04	97	218	6	PS00109
Domain	Tyr_kinase_AS	ABL2 PTK2 SYK FLT1 ROR1 AATK	9.65e-04	97	218	6	IPR008266
Domain	TYR_PHOSPHATASE_PTP	PTPRD PTPRF PTPRN2 PTPN5	1.08e-03	39	218	4	PS50055
Domain	PTPase_domain	PTPRD PTPRF PTPRN2 PTPN5	1.30e-03	41	218	4	IPR000242
Domain	Y_phosphatase	PTPRD PTPRF PTPRN2 PTPN5	1.30e-03	41	218	4	PF00102
Domain	VWA_2	INTS6L INTS6	1.33e-03	5	218	2	PF13519
Domain	Tyr_Pase_AS	PTPRD PTPRF PTPRN2 DUSP8 PTPN5	1.63e-03	73	218	5	IPR016130
Domain	Acid_Pase_AS	ACP2 ACP3	1.97e-03	6	218	2	IPR033379
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SPEG BCL9 WASHC2A BIRC6 RYR1 TNRC18 WIZ PTPRF SBF1 KLHL21 NFX1 TTC5 PREX1 MED12 HOXB13 PLXNA3 TEAD2 CRYBG2 SZT2 ZNF316 RHOT2 TNRC6C ARHGAP35 CTDNEP1 ZNF865 WDR59 NCOR2 KMT2D AATK SLC2A4RG SND1 MTHFR ZNF335 SBF2 RAI1	1.13e-14	1105	227	35	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	BIRC6 LRIG2 PWWP2A NLGN3 TNRC18 SAMD9L MGA PREX1 MED12 ARHGEF18 VARS2 ALPK1 ARHGAP35 WDFY4 WDR59 EPN2 ATAD3B ATAD3A PLEKHG3 SBF2 DNAH17 SLX4 KIF1C	2.41e-13	493	227	23	15368895
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	CHL1 SPEG DSCAML1 LRIG2 IGSF10 PTPRD PTPRF ROBO3 FLT1 ROR1 NECTIN3 HMCN1 LRIG1 IGSF1	4.00e-12	162	227	14	25826454
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	PFKL BIRC6 DSCAML1 RYR1 GMPS IGSF10 ASB18 SAMD9L WIZ PTPRN2 EIF3L CHD6 DOP1B MXRA5 MYO19 ROR1 ZNF316 ZC2HC1C DROSHA PCIF1 RAI1	1.98e-08	736	227	21	29676528
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	DUSP28 BIRC6 GMPS WIZ PTPRD PTPRF SBF1 PTPRN2 TNRC6A RCAN1 DUSP8 SMPD4 PPEF2 CTDNEP1 KIF7 PTPN5 NCOR2 KMT2D CSPG5 SBF2 LTBP1 HADHB SNTB2 TP53BP2 HDLBP	2.91e-08	1049	227	25	27880917
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ERAP1 BIRC6 DSCAML1 RAB3GAP2 CHD6 PREX1 DOP1B FNDC3A ALPK1 TNRC6C ARHGAP35 AATK	3.44e-08	225	227	12	12168954
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PNKP NAP1L4 PFKL PWWP2A MAN1A2 WIZ SBF1 EIF3L NFX1 TNRC6A CHD6 TADA3 PREX1 MED12 POLR1A VPS72 DIDO1 EPN2 INTS6 MICALL2 SND1 DROSHA PLEKHG3 EIF3G EIF4G3 EDRF1 MAN1B1 SNTB2 HDLBP	1.83e-07	1497	227	29	31527615
Pubmed	Human transcription factor protein interaction networks.	NAP1L4 BCL9 WASHC2A HOXB9 HOXC9 WIZ EIF3L ZBTB21 TNRC6A CHD6 DLX6 MGA TADA3 TEAD2 VPS72 PHF23 DIDO1 RHOT2 TNRC6C KIF7 NCOR2 ATAD3B KMT2D ATAD3A HADHB EIF3G SLX4 SNTB2	2.41e-07	1429	227	28	35140242
Pubmed	LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers.	LRIG2 LRIG3 LRIG1	2.74e-07	3	227	3	27628597
Pubmed	Redistribution of LRIG proteins in psoriasis.	LRIG2 LRIG3 LRIG1	2.74e-07	3	227	3	18037903
Pubmed	LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes.	LRIG2 LRIG3 LRIG1	2.74e-07	3	227	3	33469151
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	WDR46 PFKL WASHC2A PTK2 HOXB9 WIZ SBF1 NFX1 TNRC6A MGA TADA3 RC3H2 POLR1A ARHGAP35 ATAD3B SND1 EIF4G3 PLIN3 HDLBP	3.46e-07	724	227	19	36232890
Pubmed	cDNAs with long CAG trinucleotide repeats from human brain.	TNRC18 TNRC6A MED12 NCOR2 KMT2D	3.47e-07	23	227	5	9225980
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ACP3 PFKL PTK2 GMPS NLGN3 TNRC18 PTPRN2 NGEF KATNIP CHD6 VPS37A POLR1A FAM53A CCDC32 APBB2 ARHGEF18 TNRC6C ARHGAP35 PLBD2 NCOR2 INTS6 ATAD3B ATAD3A PLEKHG3 SBF2 EIF4G3 MAN1B1 RAI1	5.48e-07	1489	227	28	28611215
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	BCL9 PTK2 ZNF469 TNRC18 MGA MAGEL2 PHF23 WT1 ARHGEF18 NCOR2 AATK INAVA EIF4G3 TP53BP2	1.07e-06	430	227	14	35044719
Pubmed	Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes.	PLXNA3 CRYBG2 MXRA5 BSDC1 DIDO1 PRKAG3 FCAMR	1.36e-06	84	227	7	15203218
Pubmed	Functional proteomics mapping of a human signaling pathway.	PNKP PFKL MAN1A2 PTPRF EIF3L GLUL CHD6 MGA RHOT2 EPN2 NCOR2 KMT2D DROSHA PLIN3 TP53BP2 HDLBP	2.02e-06	591	227	16	15231748
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	ERAP1 ACP3 DSCAML1 TNRC18 SBF1 RAB3GAP2 ZBTB21 MGA FLT1 VPS37A VPS72 ZNF316 ARHGAP35 ZNF335 HADHB EIF3G MAN1B1	3.34e-06	689	227	17	36543142
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NAP1L4 PFKL BCL9 GMPS PRAM1 TNRC18 WIZ RAB3GAP2 ZBTB21 SYK TADA3 MED12 ZNF316 WT1 DIDO1 NCOR2 KMT2D SND1 HADHB PLIN3 RAI1 HDLBP	3.87e-06	1103	227	22	34189442
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	BIRC6 WIZ RAB3GAP2 ZBTB21 TNRC6A CHD6 MGA MED12 SFMBT1 CHAMP1 NCOR2 KMT2D TP53BP2	4.29e-06	418	227	13	34709266
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF469 WIZ HMCN2 KLHL21 ZBTB21 TNRC6A MGA TADA3 VPS72 RNF31 P3H3 ZNF316 RHOT2 CHAMP1 KIF7 LRIG3 NCOR2 INTS6 ATAD3B MTHFR DROSHA RAI1	4.65e-06	1116	227	22	31753913
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	BCL9 RYR1 FER1L6 PTPRN2 CHD6 PREX1 MXRA5 NR4A3 RHOT2 KIF7 NCOR2 ATAD3B KMT2D SMCR8 SNTB2 RAI1	5.33e-06	638	227	16	31182584
Pubmed	DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy.	CTSF MAOB GLI4 NGEF PLXNA3 VPS37A PHF23 P3H3 CARS1 WT1 ZC3HC1 ZC2HC1C	5.61e-06	364	227	12	31391242
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	DUSP28 AZGP1 NCAPH2 BIRC6 GMPS SLC12A9 PTPRN2 RAB3GAP2 GLUL MGA TADA3 MED12 DPH1 VPS72 MLX SZT2 PHF23 CCDC32 VARS2 WDR59 INTS6 ATAD3A LTBP1 HDLBP	7.21e-06	1327	227	24	32694731
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	NCAPH2 PFKL WASHC2A PTPRD KLHL21 TIMELESS DOP1B STX8 C12orf71 VPS72 ZC3HC1 ARHGEF18 SMPD4 RHOT2 ALPK1 ATAD3B LRIG1 ATAD3A DNAH17 LTBP1 INAVA DCBLD2 SLX4	7.75e-06	1242	227	23	30973865
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	AZGP1 WDR46 PFKL BIRC6 PTK2 GMPS STK4 SBF1 EIF3L MGA MED12 PARP12 POLR1A RNF31 MYO19 RHOT2 WDR59 NCOR2 SND1 ATAD3A PLEKHG3 HADHB TP53BP2 HDLBP	9.94e-06	1353	227	24	29467282
Pubmed	Lrig2 Negatively Regulates Ectodomain Shedding of Axon Guidance Receptors by ADAM Proteases.	LRIG2 LRIG3 LRIG1	1.50e-05	8	227	3	26651291
Pubmed	In vivo analysis of Lrig genes reveals redundant and independent functions in the inner ear.	LRIG2 LRIG3 LRIG1	1.50e-05	8	227	3	24086156
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	EXT2 PTPRF SLC12A9 RAB3GAP2 EIF3L RHBDD3 TIMELESS POLR1A FNDC3A RHOT2 CTDNEP1 ATAD3B LRIG1 SND1 ATAD3A HADHB EIF4G3 MAN1B1 HDLBP	1.56e-05	942	227	19	31073040
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NAP1L4 WIZ RAB3GAP2 MGA MED12 VPS72 DIDO1 ARHGAP35 CHAMP1 KMT2D SND1 PLIN3 TP53BP2 HDLBP	1.73e-05	549	227	14	38280479
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	AZGP1 RYR1 TNRC6A GLUL PLXNA3 FLT1 SZT2 ABCC5 ZC3HC1 ALPK1 INTS6 KMT2D ZNF335 EIF4G3	1.84e-05	552	227	14	10737800
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	BCL9 PTK2 LRIG2 NLGN3 WIZ PTPRD SBF1 PTPRN2 ZBTB21 NGEF GLUL MGA ARHGEF18 DIDO1 KIF7 WDR91 NCOR2 RAI1 TP53BP2	2.10e-05	963	227	19	28671696
Pubmed	Identification of orphan ligand-receptor relationships using a cell-based CRISPRa enrichment screening platform.	PTPRD PTPRF KIR3DL1 ROR1	2.36e-05	26	227	4	36178190
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	FBXO17 PWWP2A WIZ KLHL21 MGA TADA3 SFMBT1 RC3H2 ZNF316 DIDO1 CHAMP1 KMT2D ATAD3A	2.56e-05	495	227	13	27705803
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	WASHC2A BIRC6 STK4 RAB3GAP2 EIF3L TNRC6A CHD6 MGA POLR1A ARHGEF18 SMPD4 FNDC3A NECTIN3 WDR59 EIF3G TGS1	2.92e-05	733	227	16	34672954
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	RETSAT WASHC2A LRIG2 RHBDD3 DOP1B STX8 APBB2 FNDC3A WDR59 WDR91 LRIG3 LRIG1 SMCR8	3.09e-05	504	227	13	34432599
Pubmed	The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea.	LRIG2 LRIG3	4.24e-05	2	227	2	15203213
Pubmed	Adhesion-dependent regulation of p190RhoGAP in the developing brain by the Abl-related gene tyrosine kinase.	ABL2 ARHGAP35	4.24e-05	2	227	2	15084284
Pubmed	No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	19874556
Pubmed	Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	27708262
Pubmed	Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome.	HOXB13 IL17RB	4.24e-05	2	227	2	17453342
Pubmed	Co-occurrence of mutations in KIF7 and KIAA0556 in Joubert syndrome with ocular coloboma, pituitary malformation and growth hormone deficiency: a case report and literature review.	KATNIP KIF7	4.24e-05	2	227	2	32164589
Pubmed	Genomic testing for sensitivity of breast cancer to hormonal therapy.	HOXB13 IL17RB	4.24e-05	2	227	2	16609001
Pubmed	Relocation of Syk protein-tyrosine kinase to the actin filament network and subsequent association with Fak.	PTK2 SYK	4.24e-05	2	227	2	9342235
Pubmed	Correlation between LRIG1 and LRIG2 expressions and expression of 11 tumor markers, with special reference to tumor suppressors, in CIN and normal cervical epithelium.	LRIG2 LRIG1	4.24e-05	2	227	2	21632100
Pubmed	A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen.	HOXB13 IL17RB	4.24e-05	2	227	2	16609019
Pubmed	Down-regulation of leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) in HP75 pituitary adenoma cell line.	LRIG2 LRIG3	4.24e-05	2	227	2	17393120
Pubmed	Investigation of killer cell immunoglobulin-like receptor gene diversity in KIR3DL1 and KIR3DS1 in a transplant population.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	18331531
Pubmed	Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	16805919
Pubmed	The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.	HOXB13 IL17RB	4.24e-05	2	227	2	17008703
Pubmed	HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease.	HOXB13 IL17RB	4.24e-05	2	227	2	23497539
Pubmed	Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	19211742
Pubmed	Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	35192601
Pubmed	Molecular characterization of the tumor-associated antigen AAA-TOB3.	ATAD3B ATAD3A	4.24e-05	2	227	2	16909202
Pubmed	The mouse gene Ptprf encoding the leukocyte common antigen-related molecule LAR: cloning, characterization, and chromosomal localization.	PTPRD PTPRF	4.24e-05	2	227	2	7665159
Pubmed	Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	37647275
Pubmed	Association of the KIR3DS1013 and KIR3DL1004 alleles with susceptibility to ankylosing spondylitis.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	20131260
Pubmed	Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	25112829
Pubmed	Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	17694054
Pubmed	Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression.	LRIG2 LRIG1	4.24e-05	2	227	2	22484910
Pubmed	Prognostic significance of LRIG2 and LRIG3 proteins in urothelial bladder carcinoma.	LRIG2 LRIG3	4.24e-05	2	227	2	34839782
Pubmed	Contribution of functional KIR3DL1 to ankylosing spondylitis.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	20818412
Pubmed	Distinct roles for the Charcot-Marie-Tooth disease-causing endosomal regulators Mtmr5 and Mtmr13 in axon radial sorting and Schwann cell myelination.	SBF1 SBF2	4.24e-05	2	227	2	34718573
Pubmed	A method for killer-cell immunoglobulin-like receptor (KIR) 3DL1/3DS1 genotyping using DNA recovered from frozen plasma.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	23524032
Pubmed	Epigenetic silencing of novel tumor suppressors in malignant melanoma.	SYK HOXB13	4.24e-05	2	227	2	17145863
Pubmed	Allele diversity of the killer cell immunoglobulin-like receptors KIR3DL1/S1 and the combination with their HLA ligands in Mexican Mestizos from Mexico City.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	30365992
Pubmed	Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (Fractalkine).	SYK CX3CL1	4.24e-05	2	227	2	16148119
Pubmed	Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	17182560
Pubmed	Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	19008943
Pubmed	Syk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages.	SYK CX3CL1	4.24e-05	2	227	2	21388954
Pubmed	Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study.	HOXB13 IL17RB	4.24e-05	2	227	2	26728744
Pubmed	Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues.	HMCN2 HMCN1	4.24e-05	2	227	2	32035013
Pubmed	The Abl-related gene tyrosine kinase acts through p190RhoGAP to inhibit actomyosin contractility and regulate focal adhesion dynamics upon adhesion to fibronectin.	ABL2 ARHGAP35	4.24e-05	2	227	2	17652459
Pubmed	HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	19386717
Pubmed	ATAD 3A and ATAD 3B are distal 1p-located genes differentially expressed in human glioma cell lines and present in vitro anti-oncogenic and chemoresistant properties.	ATAD3B ATAD3A	4.24e-05	2	227	2	18639545
Pubmed	Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	28942035
Pubmed	The profile of KIR3DL1 and KIR3DS1 alleles in an African American population resembles that found in African populations.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	20230527
Pubmed	Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	11098931
Pubmed	Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma.	LRIG3 LRIG1	4.24e-05	2	227	2	23165628
Pubmed	Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms' tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia.	ROR1 WT1	4.24e-05	2	227	2	18604725
Pubmed	Lysosomal integral membrane protein type-2 (LIMP-2/SCARB2) is a substrate of cathepsin-F, a cysteine protease mutated in type-B-Kufs-disease.	CTSF SCARB2	4.24e-05	2	227	2	25576872
Pubmed	WT1 regulates HOXB9 gene expression in a bidirectional way.	HOXB9 WT1	4.24e-05	2	227	2	34508900
Pubmed	Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes.	KIR3DL1 KIR3DS1	4.24e-05	2	227	2	19411600
Pubmed	Possible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints.	PTK2 FLT1	4.24e-05	2	227	2	12023386
Pubmed	The AAA+ protein ATAD3 has displacement loop binding properties and is involved in mitochondrial nucleoid organization.	ATAD3B ATAD3A	4.24e-05	2	227	2	17210950
Pubmed	A novel receptor-type protein tyrosine phosphatase with a single catalytic domain is specifically expressed in mouse brain.	PTPRD PTPRF PTPRQ	4.36e-05	11	227	3	7832766
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	NAP1L4 PFKL GMPS STK4 WIZ ZBTB21 PARP12 DIDO1 ARHGAP35 CHAMP1 SND1 EIF3G EIF4G3 SMCR8 DEPDC1B PLIN3 TP53BP2 HDLBP	4.72e-05	934	227	18	33916271
Pubmed	K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.	EXT2 BIRC6 RAB3GAP2 RHBDD3 STX8 VPS37A RNF31 PLBD2 EPN2 NCOR2 KMT2D PCIF1 HADHB TP53BP2	4.89e-05	604	227	14	38803224
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SBF1 KLHL21 ZBTB21 TNRC6A MED12L SZT2 SMPD4 DIDO1 FNDC3A CHAMP1 LRIG3 IGSF1 RAI1	5.06e-05	529	227	13	14621295
Pubmed	A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export.	ACP2 RETSAT GMPS SLC12A9 STX8 POLR1A CCDC32 ATAD3B ATAD3A SCARB2 KIF1C	5.99e-05	392	227	11	33144569
Pubmed	Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo.	LRIG2 IGSF10 LRIG3 LRIG1	7.03e-05	34	227	4	18848646
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	BCL9 TNRC18 WIZ ZBTB21 MGA MED12 CHAMP1 KMT2D RAI1	7.31e-05	268	227	9	33640491
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	ERAP1 SPEG ACP2 EXT2 PFKL NEU2 MAN1A2 SBF1 RAB3GAP2 GLUL PARP12 P3H3 VARS2 PLBD2 NCOR2 ATAD3B LRIG1 SND1 ATAD3A LTBP1 HADHB MAN1B1 HDLBP	8.60e-05	1451	227	23	30550785
Pubmed	MED12 regulates a transcriptional network of calcium-handling genes in the heart.	RYR1 MED12 SLC8A2	9.47e-05	14	227	3	28724790
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	GMPS WIZ MED12 HOXB13 DIDO1 CHAMP1 NCOR2 KMT2D	1.07e-04	220	227	8	35785414
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	PFKL PTPRF EIF3L DOP1B RHOT2 PTPN5 INTS6 ATAD3B ATAD3A HADHB MAN1B1 SNTB2 TP53BP2	1.13e-04	573	227	13	28330616
Pubmed	Interaction network of human early embryonic transcription factors.	BCL9 HOXB9 TNRC18 WIZ MGA MED12 NCOR2 KMT2D SLX4 RAI1	1.14e-04	351	227	10	38297188
Pubmed	Sequence-ready 1-Mb YAC, BAC and cosmid contigs covering the distal imprinted region of mouse chromosome 7.	NAP1L4 DUSP8 CARS1	1.18e-04	15	227	3	10691133
Pubmed	Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface.	NEU2 MAN1A2 MAN1B1	1.18e-04	15	227	3	8892864
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	PNKP WIZ MGA MED12 VPS72 CHAMP1 KMT2D	1.20e-04	167	227	7	20362541
Interaction	TOP3B interactions	SPEG PFKL BCL9 WASHC2A BIRC6 RYR1 TNRC18 WIZ PTPRF SBF1 KLHL21 NFX1 TTC5 PREX1 MED12 HOXB13 PLXNA3 RC3H2 TEAD2 CRYBG2 SZT2 ZNF316 RHOT2 TNRC6C ARHGAP35 CTDNEP1 ZNF865 WDR59 NCOR2 KMT2D AATK SLC2A4RG SND1 ATAD3A MTHFR ZNF335 SBF2 HADHB RAI1 HDLBP	5.97e-08	1470	219	40	int:TOP3B
Interaction	TMPRSS4 interactions	HLA-DQB1 PFKL LRIG2 PLXNA3 STX8 SMPD4 FNDC3A RHOT2 LRIG3 ATAD3B LRIG1 MTHFR SCARB2 SMCR8 MAN1B1	1.91e-06	314	219	15	int:TMPRSS4
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CHL1 SPEG DSCAML1 LRIG2 IGSF10 HMCN2 PTPRD PTPRF ROBO3 FLT1 MXRA5 ROR1 NECTIN3 LRIG3 HMCN1 LRIG1 MYBPC2	6.81e-14	161	160	17	593
GeneFamily	Ataxins\|Trinucleotide repeat containing	TNRC18 TNRC6A MED12 TNRC6C NCOR2 KMT2D	6.74e-08	25	160	6	775
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRD PTPRF PTPRN2 PTPRQ	3.14e-05	21	160	4	813
GeneFamily	Fibronectin type III domain containing	CHL1 DSCAML1 PTPRD PTPRF PTPRQ ROBO3 FNDC3A MYBPC2	9.03e-05	160	160	8	555
GeneFamily	Immunoglobulin like domain containing	CHL1 DSCAML1 HMCN2 ROBO3 FLT1 MXRA5 NECTIN3 IGSF1	3.27e-04	193	160	8	594
GeneFamily	Mannosidases alpha class 1	MAN1A2 MAN1B1	4.62e-04	4	160	2	1193
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	SBF1 SBF2 SMCR8	1.36e-03	25	160	3	504
GeneFamily	Basic helix-loop-helix proteins\|MAX dimerization proteins	MGA MLX	1.59e-03	7	160	2	637
GeneFamily	Class II Cys-based phosphatases\|Acid phosphatases	ACP2 ACP3	1.59e-03	7	160	2	1071
GeneFamily	Fibulins	HMCN2 HMCN1	2.10e-03	8	160	2	556
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	NGEF PREX1 ARHGEF18 PLEKHG3	2.78e-03	66	160	4	722
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage_2\|356C / Donor, Lineage, Cell class and subclass (all cells)	ABL2 HLA-DQB1 GLUL OGFRL1 FLT1 RCAN1 NR4A3 WDFY4 PRKAG3 SLC8A2	2.91e-08	180	225	10	b94618c1c2592ecf7da3535294aee9243755247a
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	LRIG2 PRAM1 MED12L MGA SZT2 BSDC1 WDFY4 MTHFR KIF1C	1.45e-07	162	225	9	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	CV-Healthy-7\|CV / Virus stimulation, Condition and Cluster	PNKP GLI4 OGFRL1 NR4A3 LRIG1 SNX25 SMCR8 MAN1B1 RAI1	4.27e-07	184	225	9	0e5cc77aaa73ceb791f8be7456177577fd2e5586
ToppCell	CV-Healthy-7\|Healthy / Virus stimulation, Condition and Cluster	PNKP GLI4 OGFRL1 NR4A3 LRIG1 SNX25 SMCR8 MAN1B1 RAI1	4.47e-07	185	225	9	1979d189c204f4c2893e3170a514ee7d5523406c
ToppCell	Children_(3_yrs)-Immune-dendritic_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GGN HLA-DQB1 SMIM20 MED12L NR4A3 WDFY4 SLC4A3 EHHADH	1.68e-06	161	225	8	cd41abb7ae659d3d314281783a0aaad562b26037
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HMCN2 PTPRN2 SPOCK3 DLX6 ARHGEF18 PHOX2A DNAH17 SLC28A2	3.00e-06	174	225	8	742c73c9e090848b464323cb17579b86658c6792
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HMCN2 PTPRN2 SPOCK3 DLX6 ARHGEF18 PHOX2A DNAH17 SLC28A2	3.00e-06	174	225	8	7fed9722e64c60843092f2ba71256e3043011ef6
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	FBXO17 FZD4 TNRC18 SZT2 ZC2HC1C MICALL2 SBF2	5.46e-06	134	225	7	72d7eec3aeb43319f3ef81bb5518fae8d8880136
ToppCell	normal_Lymph_Node-Myeloid_cells-CD1c+_DCs\|normal_Lymph_Node / Location, Cell class and cell subclass	HLA-DQB1 ACP3 PRAM1 HCAR3 OGFRL1 LILRA2 NR4A3 SLC4A3	6.95e-06	195	225	8	cd4d61a463e0e87b711e08ceedee5bef5d735e64
ToppCell	Healthy-CD4+_T_activated\|World / disease group, cell group and cell class	MYCBPAP SAMD9L DPH1 ZC3HC1 LRIG1 SLC28A2 INAVA	7.28e-06	140	225	7	407691970ec72a3afb45e431cf48814546b8acff
ToppCell	Monocytes-cDCs\|World / Immune cells in Kidney/Urine in Lupus Nephritis	HLA-DQB1 ACP3 PRAM1 SLC12A9 SYK OGFRL1 WDFY4 SLC4A3	7.49e-06	197	225	8	3388c104af4c6a05988e102627e0c5e34d9dcc45
ToppCell	Control_saline-Hematopoietic_Myeloid-Dendritic_cells-pDC\|Control_saline / Treatment groups by lineage, cell group, cell type	PTCRA FAM178B SYK OGFRL1 LILRA2 NR4A3 WDFY4 PLIN3	8.06e-06	199	225	8	34b95e27581bb127e0b921e9c068dc094cb86b37
ToppCell	Control_saline-Hematopoietic_Myeloid-Dendritic_cells\|Control_saline / Treatment groups by lineage, cell group, cell type	PTCRA FAM178B SYK OGFRL1 LILRA2 NR4A3 WDFY4 PLIN3	8.36e-06	200	225	8	1559844b3116d41a69081e4ee89e64744a760181
ToppCell	Healthy-CD4+_T_activated\|Healthy / disease group, cell group and cell class	MYCBPAP SAMD9L DPH1 ZC3HC1 LRIG1 SLC28A2 INAVA	9.17e-06	145	225	7	45e8089fdf7d6f69b383816d8945e39fba24c873
ToppCell	remission-multiplets\|remission / disease stage, cell group and cell class	TLCD4 IGSF10 ZNF469 MED12L ALPK1 SLC28A2 TP53BP2	1.09e-05	149	225	7	e9974260a5f2999b363f306cae005698c912893a
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-DQB1 IRAK2 SBF1 SLC12A9 SYK ROR1 WDFY4	2.67e-05	171	225	7	1018d7bd378ce20bee56a77d5851b3538c55098c
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-DQB1 IRAK2 SBF1 SLC12A9 SYK ROR1 WDFY4	2.67e-05	171	225	7	173bb5318fdbaef6e695b6f9e3e0ff4a5432a1a4
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-DQB1 IRAK2 SBF1 SLC12A9 SYK ROR1 WDFY4	2.67e-05	171	225	7	6bda333bb751d7835a04f21ac959eea79f2516aa
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	MAOB HOXC9 PTPRD PTPRQ MXRA5 FMO3 HMCN1	3.32e-05	177	225	7	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	MAOB HOXC9 PTPRD PTPRQ MXRA5 FMO3 HMCN1	3.32e-05	177	225	7	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	3'_v3-bone_marrow-Mast\|bone_marrow / Manually curated celltypes from each tissue	MAOB GLUL MED12L KLHDC7A NR4A3 LTBP1 IL3RA	3.70e-05	180	225	7	b37ee81b792213d6595b4ec65d04bc35d83321c7
ToppCell	ICU-NoSEP-Myeloid-tDC\|ICU-NoSEP / Disease, Lineage and Cell Type	IGSF10 PTPRF MED12L FLT1 SLC4A3 PLBD2 IL3RA	3.70e-05	180	225	7	be665e801512f6aaf6b3ecb26153bbdeb24619ac
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FBXO17 DSCAML1 PTPRD NGEF IL17RB EHHADH PRLR	4.11e-05	183	225	7	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	3'_v3-GI_small-bowel-Myeloid_Dendritic\|GI_small-bowel / Manually curated celltypes from each tissue	HLA-DQB1 IRAK2 FBXO17 DSCAML1 PTK2 WDFY4 SLC4A3	4.11e-05	183	225	7	6109199cf25b28831193a5ed7925b5bf38c6eb43
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STK4 CX3CL1 FLT1 CARS1 FNDC3A EIF4G3 TP53BP2	4.25e-05	184	225	7	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|normal_Lung / Location, Cell class and cell subclass	ZNF469 HMCN2 PTPRD MXRA5 P3H3 HMCN1 LTBP1	4.25e-05	184	225	7	0b336489c10e8c3c957795dd845454f03404382b
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CHL1 DSCAML1 PTPRD MXRA5 ROR1 LRIG1 LTBP1	4.55e-05	186	225	7	4d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_3\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	IRAK2 RYR1 DUSP8 ZNF316 ZC3HC1 WDFY4 KIF1C	4.71e-05	187	225	7	1eed2c1a05e80a7c8f639437c117afe0c18dfb0c
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	NAP1L4 PTK2 TNRC6A CHD6 IL17RB WDR59 LRIG3	5.57e-05	192	225	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SAMD9L GSN-AS1 MED12L LILRA2 FIGNL2 IL3RA PRLR	5.57e-05	192	225	7	935a4a36881a9fa4daa02cba96af07f6686ed8d6
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HLA-DQB1 PRAM1 SYK PREX1 OGFRL1 NR4A3 WDFY4	5.57e-05	192	225	7	5417f024fcc89eaeab33f4a2c6421d1cfabd681b
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAOB PTPRF PTPRN2 TNRC6A GLUL FOSB PRLR	5.94e-05	194	225	7	92b39a935e8c577eb1123d706d168fa13cf3344c
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DQB1 RYR1 ZNF469 SYK WDFY4 SLC4A3 IL3RA	6.14e-05	195	225	7	4cbc36fb3ef9aef61367d3b37070a9a85fae1418
ToppCell	facs-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAOB IGSF10 PTPRF GLUL P3H3 FOSB ABCC5	6.14e-05	195	225	7	c4648c0332c3826776f9ad3f5f803dbac2b4c0c0
ToppCell	COVID-19_Severe-cDC\|COVID-19_Severe / disease group, cell group and cell class	HLA-DQB1 ACP3 RYR1 SLC12A9 OGFRL1 NR4A3 SLC4A3	6.14e-05	195	225	7	6419090b19de7b5d5140eaecf231860273da2c0d
ToppCell	PBMC-Control-cDC_3\|Control / Compartment, Disease Groups and Clusters	HLA-DQB1 STK4 ZNF469 RC3H2 DIDO1 WDFY4 SLC4A3	6.34e-05	196	225	7	09d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCell	healthy_donor-Myeloid-Dendritic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HLA-DQB1 ACP3 EIF3L SYK OGFRL1 WDFY4 SLC4A3	6.34e-05	196	225	7	ea590b8ea3d13ff93cb5863a44936b0cfdf3b868
ToppCell	healthy_donor-Myeloid-Dendritic-cDC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HLA-DQB1 ACP3 EIF3L SYK OGFRL1 WDFY4 SLC4A3	6.34e-05	196	225	7	aac79fc45cab4a16e2fa02652ece0999591261a5
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CHL1 IGSF10 PTPRD MXRA5 ALPK1 MICALL2 LTBP1	6.54e-05	197	225	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABL2 HLA-DQB1 IRAK2 IGSF10 PREX1 FLT1 NR4A3	6.54e-05	197	225	7	b597c292fc1cb381a4325fed15a32966c38def28
ToppCell	VE-mDC2-\|VE / Condition, Cell_class and T cell subcluster	HLA-DQB1 PRAM1 SYK OGFRL1 LILRA2 NR4A3 SLC4A3	6.54e-05	197	225	7	6629588819ec31a7e4f33b94b8c035145a5f6c17
ToppCell	VE-mDC2\|VE / Condition, Cell_class and T cell subcluster	HLA-DQB1 PRAM1 SYK OGFRL1 LILRA2 NR4A3 SLC4A3	6.54e-05	197	225	7	e3172102ad17c92c3038cad37bf933eb04351048
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	HLA-DQB1 IRAK2 PRAM1 HCAR3 SYK LILRA2 WDFY4	6.75e-05	198	225	7	898be90c906ebc806a764ae6c21bbf84649b6b30
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABL2 HLA-DQB1 IRAK2 MED12L FLT1 NR4A3 WDFY4	6.97e-05	199	225	7	b0a906586e58009f5ed9272fc29ba28e49c85ee6
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	MAN1A2 WIZ PTPRF ROR1 NECTIN3 CTDNEP1 LTBP1	6.97e-05	199	225	7	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Sepsis-ICU-NoSEP-Myeloid-tDC\|ICU-NoSEP / Disease, condition lineage and cell class	IGSF10 PTPRF MED12L FLT1 ZC2HC1C PLBD2 IL3RA	6.97e-05	199	225	7	90ddd686b8f39c6f6134b9b048396cebcf8d0448
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HLA-DQB1 STK4 GSN-AS1 SYK PREX1 NR4A3 WDFY4	6.97e-05	199	225	7	5abfbccae147d399e4234f90ae5cd9529abe4dd1
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2\|Cerebellum / BrainAtlas - Mouse McCarroll V32	FAM178B CCDC168 HMCN2 ZNF865 KIF7 EHHADH	6.97e-05	137	225	6	9324b55eac55e0cc1e8e450a4b5374d12e9587a3
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	FAM178B CCDC168 HMCN2 ZNF865 KIF7 EHHADH	6.97e-05	137	225	6	032f8409d0d179e254c8ff632afbda78852a9889
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	IGSF10 NLGN3 LRGUK HMCN2 RHBDD3 LRIG1	6.97e-05	137	225	6	a69976938d4e89315ec0be3a332b91ddf3799d65
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	FAM178B CCDC168 HMCN2 ZNF865 KIF7 EHHADH	6.97e-05	137	225	6	265a4a50e48b13c8b3b0730f818235f71fbd6baa
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	AZGP1 FAM178B GLUL CHD6 DLX6 FLT1 EPN2	7.19e-05	200	225	7	e16bde12326f0cfc4d03f9307cba0e21ea2389cb
ToppCell	COVID-19-COVID-19_Convalescent-Myeloid-cDC\|COVID-19_Convalescent / Disease, condition lineage and cell class	HLA-DQB1 PTK2 SYK OGFRL1 LILRA2 FOSB WDFY4	7.19e-05	200	225	7	ac9d7927863348a752444d2e80269a5eead943b7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 IGSF10 NUTM1 ASB18 CTDNEP1 DNAH17	7.26e-05	138	225	6	2e46d546ad962aa0fde5b1c18c2a5370a4424e9f
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	RYR1 FER1L6 MYO18B BNIP5 DNAH17	8.36e-05	88	225	5	b7b55f51af8ffa82813a4747580985a430da9ed1
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	RYR1 FER1L6 MYO18B BNIP5 DNAH17	8.36e-05	88	225	5	b4620e79ea80681305434707e87cb02a7c6a5e4f
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))--\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	RYR1 FER1L6 MYO18B BNIP5 DNAH17	8.36e-05	88	225	5	7992f8e621edf464bffcb70a6cc5f3b60c1d96f8
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF469 MYO18B BNIP5 WT1 RHOT2	9.81e-05	91	225	5	b0658e020f80e56fab9d2aa07e321d9b33d7af2c
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	STK4 IL17RB FOSB PPEF2 KMT2D AATK	1.03e-04	147	225	6	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	Club_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	MAP6D1 IGSF10 WIZ HMCN2 CX3CL1 FMO3	1.03e-04	147	225	6	9211242a8e40d50414d310940616eccce299a7f8
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	PTCRA NCAPH2 STK4 NFX1 TIMELESS ROR1 RHOT2 ALPK1 ARHGAP35 NCOR2 MTHFR EDRF1	6.99e-07	199	224	12	3684_DN
Drug	Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A	ERAP1 NCAPH2 PTPRF SBF1 ROBO3 RNF31 DIDO1 EPN2 MICALL2 PLEKHG3 TGS1	4.53e-06	198	224	11	4791_DN
Drug	Reserpine [50-55-5]; Down 200; 6.6uM; PC3; HT_HG-U133A	MAP6D1 WIZ SPOCK3 RAB3GAP2 TADA3 P3H3 DUSP8 WT1 WDR59 DNAH17 TGS1	4.53e-06	198	224	11	4203_DN
Drug	Bezafibrate [41859-67-0]; Down 200; 11uM; HL60; HT_HG-U133A	NCAPH2 WIZ KATNIP TADA3 MLX FOSB MYO19 DUSP8 APBB2 PLEKHG3 EDRF1	4.53e-06	198	224	11	1275_DN
Drug	Dapsone [80-08-0]; Down 200; 16.2uM; MCF7; HT_HG-U133A	ERAP1 NCAPH2 NFX1 RHBDD3 DOP1B CRYBG2 FNDC3A ALPK1 WDR91 ITPKC HDLBP	4.75e-06	199	224	11	5498_DN
Drug	Streptozotocin [18883-66-4]; Down 200; 15uM; PC3; HT_HG-U133A	IL17RB RC3H2 RNF31 DUSP8 WT1 APBB2 BSDC1 ALPK1 PCIF1 MAN1B1 HDLBP	4.75e-06	199	224	11	5836_DN
Drug	Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A	NCAPH2 MAN1A2 RHBDD3 ROBO3 IL17RB RCAN1 ALPK1 NECTIN3 EPN2 WDR91 EHHADH	4.75e-06	199	224	11	4985_DN
Drug	sodium beta-glycerophosphate	CHL1 ACP2 ACP3 PTK2 GAST	4.90e-06	26	224	5	CID000013170
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	BCL9 WIZ SLC12A9 KATNIP EPN2 WDR91 IGSF1 EIF4G3 PLIN3 KIF1C	2.26e-05	193	224	10	3412_DN
Drug	Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; HL60; HT_HG-U133A	CTSF PTCRA MAN1A2 PTPRF PTPRN2 RAB3GAP2 RHBDD3 TIMELESS ROR1 SCARB2	2.58e-05	196	224	10	2389_UP
Drug	THIP Hydrochloride; Down 200; 22.6uM; HL60; HT_HG-U133A	PTCRA NCAPH2 ZNF688 SLC12A9 APBB2 NR4A3 RHOT2 ARHGAP35 CSPG5 SCARB2	2.70e-05	197	224	10	3132_DN
Drug	Gramine [87-52-5]; Down 200; 23uM; HL60; HT_HG-U133A	PTCRA ACP3 PTPRN2 FLT1 LILRA2 DUSP8 APBB2 ARHGAP35 EPN2 ITPKC	2.70e-05	197	224	10	2143_DN
Drug	Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A	FZD4 SBF1 KATNIP DOP1B RNF31 MYO19 RHOT2 ITPKC ZNF335 KIF1C	2.94e-05	199	224	10	7192_DN
Drug	Trichlormethiazide [133-67-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A	PNKP ERAP1 NCAPH2 SLC12A9 RHBDD3 ROBO3 PLXNA3 APBB2 WDR91 HDLBP	3.07e-05	200	224	10	4783_DN
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A	ABL2 ERAP1 RHBDD3 RCAN1 FOSB APBB2 NR4A3 SCARB2 EDRF1	8.00e-05	181	224	9	2675_UP
Drug	lead tartrate	ACP2 ACP3	9.64e-05	2	224	2	CID000061219
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	ERAP1 FZD4 WIZ RAB3GAP2 NFX1 FMO3 SLC8A2 EDRF1 PRLR	9.85e-05	186	224	9	4463_UP
Drug	Grgd Peptide	PTK2 FNDC3A DCBLD2	1.07e-04	10	224	3	CID000126679
Drug	AC1L1FVW	ACP2 ACP3 RHBDL1 PTPN5	1.15e-04	26	224	4	CID000003416
Drug	Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; MCF7; HT_HG-U133A	PTCRA WIZ NFX1 RCAN1 P3H3 FOSB NR4A3 EPN2 KMT2D	1.16e-04	190	224	9	5674_UP
Drug	Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	MAP6D1 WIZ RHBDD3 TIMELESS PLXNA3 RNF31 APBB2 EPN2 CSPG5	1.21e-04	191	224	9	2789_DN
Drug	Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A	BCL9 FZD4 RHBDD3 DPH1 ALPK1 MICALL2 LTBP1 EDRF1 KIF1C	1.21e-04	191	224	9	7438_DN
Drug	0179445-0000 [211246-22-9]; Up 200; 10uM; PC3; HT_HG-U133A	ABL2 STK4 SPOCK3 RC3H2 ROR1 DIDO1 ARHGAP35 PLEKHG3 EDRF1	1.30e-04	193	224	9	4289_UP
Drug	Iohexol [66108-95-0]; Down 200; 4.8uM; MCF7; HT_HG-U133A	WIZ NFX1 RHBDD3 RCAN1 FNDC3A ARHGAP35 WDR91 PRLR KIF1C	1.30e-04	193	224	9	3322_DN
Drug	Streptozotocin [18883-66-4]; Up 200; 15uM; PC3; HT_HG-U133A	ERAP1 NCAPH2 ZNF688 LRIG2 RAB3GAP2 PLXNA3 APBB2 SND1 ZNF335	1.36e-04	194	224	9	5836_UP
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	WIZ NFX1 GLUL TADA3 FNDC3A ARHGAP35 NCOR2 PLEKHG3 CSPG5	1.36e-04	194	224	9	3674_DN
Drug	Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A	NCAPH2 ZNF688 STK4 RAB3GAP2 FOSB APBB2 EPN2 EDRF1 KIF1C	1.41e-04	195	224	9	2681_DN
Drug	Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; PC3; HT_HG-U133A	ERAP1 NCAPH2 PTPRN2 SPOCK3 PLXNA3 WT1 RHOT2 ARHGAP35 TGS1	1.41e-04	195	224	9	7394_UP
Drug	Hydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A	PTK2 MLX RHOT2 EPN2 ITPKC MICALL2 CSPG5 KIF1C TGS1	1.41e-04	195	224	9	1687_DN
Drug	Zalcitabine [7481-89-2]; Up 200; 19uM; HL60; HT_HG-U133A	PTCRA AZGP1 PTPRN2 SPOCK3 TIMELESS FLT1 MXRA5 ALPK1 SNTB2	1.41e-04	195	224	9	2932_UP
Drug	Lidoflazine [3416-26-0]; Down 200; 8.2uM; MCF7; HT_HG-U133A	ERAP1 WIZ SPOCK3 RHBDD3 FNDC3A NECTIN3 ARHGAP35 WDR91 EDRF1	1.41e-04	195	224	9	3201_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; HL60; HT_HG-U133A	ERAP1 ACP3 NCAPH2 WIZ DPH1 RC3H2 BSDC1 ARHGAP35 EIF4G3	1.41e-04	195	224	9	2358_DN
Drug	Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A	PTCRA NCAPH2 RYR1 MAN1A2 SPOCK3 SZT2 APBB2 ZC2HC1C NCOR2	1.47e-04	196	224	9	5253_UP
Drug	Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; PC3; HT_HG-U133A	PTCRA ERAP1 STK4 TADA3 CRYBG2 APBB2 ALPK1 ARHGAP35 ZNF335	1.47e-04	196	224	9	3703_DN
Drug	Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; HL60; HT_HG-U133A	MAP6D1 WIZ PTPRF PTPRN2 RAB3GAP2 PLXNA3 SZT2 APBB2 FNDC3A	1.47e-04	196	224	9	2451_UP
Drug	Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; HL60; HT_HG-U133A	STK4 RC3H2 LILRA2 RCAN1 SZT2 APBB2 SCARB2 PCIF1 TGS1	1.47e-04	196	224	9	2718_DN
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A	CTSF NCAPH2 STK4 RAB3GAP2 ROBO3 APBB2 ALPK1 WDR59 MTHFR	1.47e-04	196	224	9	4227_DN
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	CTSF PTCRA NCAPH2 ROBO3 CRYBG2 FNDC3A RHOT2 EDRF1 PRLR	1.47e-04	196	224	9	1658_UP
Drug	fludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A	NFX1 RCAN1 SZT2 RHOT2 PHOX2A AATK PLEKHG3 SCARB2 LTBP1	1.52e-04	197	224	9	282_UP
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A	ABL2 NCAPH2 BCL9 WIZ SBF1 SYK KATNIP RHBDD3 TIMELESS	1.52e-04	197	224	9	4751_DN
Drug	aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A	ABL2 RYR1 MAN1A2 CRYBG2 LILRA2 ARHGAP35 SLC8A2 SCARB2 PRLR	1.52e-04	197	224	9	2664_UP
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; HL60; HT_HG-U133A	HDHD3 ABL2 WIZ SBF1 LILRA2 DUSP8 APBB2 EPN2 MTHFR	1.52e-04	197	224	9	3006_DN
Drug	Sulfathiazole [72-14-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A	MAP6D1 FZD4 RHBDD3 RNF31 MLX FNDC3A ARHGAP35 SND1 PRLR	1.52e-04	197	224	9	1463_DN
Drug	Cefaclor [70356-03-5]; Down 200; 10.4uM; HL60; HT_HG-U133A	ACP3 PTK2 STK4 PTPRN2 LILRA2 APBB2 NR4A3 FNDC3A EDRF1	1.52e-04	197	224	9	2483_DN
Drug	Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A	SPEG PTPRF PTPRN2 RAB3GAP2 RC3H2 MLX WT1 NCOR2 SND1	1.52e-04	197	224	9	6758_DN
Drug	Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A	NCAPH2 BCL9 SBF1 NFX1 RNF31 MLX DUSP8 ARHGAP35 PLEKHG3	1.52e-04	197	224	9	7195_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	RETSAT WIZ RHBDD3 LILRA2 RNF31 WT1 SND1 PLEKHG3 EDRF1	1.52e-04	197	224	9	1180_DN
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	ERAP1 NCAPH2 WIZ PLXNA3 ARHGAP35 WDR91 ITPKC MICALL2 EHHADH	1.52e-04	197	224	9	3308_DN
Drug	Calciferol [50-14-6]; Up 200; 10uM; PC3; HT_HG-U133A	CTSF ERAP1 NFX1 IL17RB CRYBG2 RHOT2 KMT2D MTHFR SLC28A2	1.58e-04	198	224	9	6746_UP
Drug	Megestrol acetate [595-33-5]; Down 200; 10.4uM; HL60; HT_HG-U133A	PTCRA ACP3 NCAPH2 RYR1 WIZ CRYBG2 NR4A3 ARHGAP35 CSPG5	1.58e-04	198	224	9	3091_DN
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; HL60; HG-U133A	ERAP1 NCAPH2 PTPRN2 RHBDD3 MED12 LILRA2 SZT2 EPN2 MAN1B1	1.58e-04	198	224	9	1411_UP
Drug	Lithocholic acid [434-13-9]; Up 200; 10.6uM; MCF7; HT_HG-U133A	CTSF NCAPH2 RCAN1 APBB2 FNDC3A ZC2HC1C RHOT2 SND1 EDRF1	1.58e-04	198	224	9	3433_UP
Drug	Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A	NCAPH2 BCL9 ZNF688 SBF1 WDR59 SND1 EHHADH ZNF335 TGS1	1.58e-04	198	224	9	5537_DN
Drug	Ethamivan [304-84-7]; Down 200; 18uM; MCF7; HT_HG-U133A	ERAP1 NCAPH2 RYR1 MLX NECTIN3 ITPKC EHHADH IGSF1 PRLR	1.58e-04	198	224	9	2879_DN
Drug	Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	PTPRF SBF1 PLXNA3 NECTIN3 ARHGAP35 EPN2 WDR91 IGSF1 EDRF1	1.58e-04	198	224	9	5019_DN
Drug	Amiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; HL60; HT_HG-U133A	ABL2 AZGP1 MAP6D1 HOXB9 RHBDD3 TADA3 LILRA2 APBB2 MTHFR	1.58e-04	198	224	9	3000_DN
Drug	Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; HL60; HT_HG-U133A	STK4 DOP1B APBB2 NR4A3 ARHGAP35 EPN2 SLC8A2 PHOX2A LTBP1	1.58e-04	198	224	9	2909_UP
Drug	Dicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A	ERAP1 STK4 WIZ TADA3 APBB2 ALPK1 WDR91 PRLR KIF1C	1.64e-04	199	224	9	3307_DN
Drug	Protoveratrine A [143-57-7]; Up 200; 5uM; HL60; HT_HG-U133A	CTSF MAP6D1 HOXB9 APBB2 RHOT2 WDR59 PHOX2A GAST KIF1C	1.64e-04	199	224	9	2144_UP
Drug	Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A	WIZ SBF1 KLHL21 MED12 DPH1 APBB2 EPN2 PCIF1 EIF4G3	1.64e-04	199	224	9	7203_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A	HDHD3 STK4 KLHL21 RAB3GAP2 KATNIP FOSB EPN2 NCOR2 MICALL2	1.64e-04	199	224	9	2683_DN
Drug	(cis-) Nanophine [5072-45-7]; Up 200; 26.8uM; PC3; HT_HG-U133A	PTCRA RAB3GAP2 NFX1 DOP1B SZT2 WT1 ZC2HC1C SLC28A2 IGSF1	1.64e-04	199	224	9	4543_UP
Drug	Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; HL60; HT_HG-U133A	PTCRA AZGP1 SLC12A9 SPOCK3 P3H3 WDR59 PRLR SNTB2 MYBPC2	1.64e-04	199	224	9	2990_UP
Drug	Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A	NCAPH2 BCL9 STK4 WIZ PTPRF NFX1 TIMELESS ARHGAP35 PRLR	1.64e-04	199	224	9	5286_UP
Drug	Piperacetazine [3819-00-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A	NCAPH2 PTPRF RHBDD3 RNF31 CSPG5 ZNF335 PCIF1 PRLR TGS1	1.64e-04	199	224	9	7191_DN
Drug	Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A	ERAP1 WIZ SBF1 OGFRL1 MLX PLEKHG3 IGSF1 EDRF1 KIF1C	1.64e-04	199	224	9	3435_DN
Drug	Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	ABL2 PTCRA STK4 MAN1A2 TIMELESS OGFRL1 MLX PLEKHG3 DCBLD2	1.64e-04	199	224	9	3349_DN
Drug	Diflunisal [22494-42-4]; Up 200; 16uM; PC3; HG-U133A	NCAPH2 ZNF688 WIZ PTPRF KLHL21 HOXB13 RCAN1 PLEKHG3 IGSF1	1.71e-04	200	224	9	1908_UP
Drug	Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A	NCAPH2 FZD4 STK4 WIZ KATNIP RNF31 MICALL2 LTBP1 KIF1C	1.71e-04	200	224	9	7165_DN
Drug	Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; PC3; HT_HG-U133A	WIZ RAB3GAP2 NFX1 TADA3 FLT1 WT1 WDR59 AATK MTHFR	1.71e-04	200	224	9	4095_DN
Disease	Ovarian Mucinous Adenocarcinoma	SPEG ROR1 ALPK1 AATK	8.22e-05	31	221	4	C1335167
Disease	Autistic Disorder	MAOB NLGN3 ROBO3 MAGEL2 WDFY4 SND1 MTHFR PRLR HDLBP	1.67e-04	261	221	9	C0004352
Disease	Down syndrome (implicated_via_orthology)	DSCAML1 DOP1B RCAN1	1.76e-04	15	221	3	DOID:14250 (implicated_via_orthology)
Disease	Myopathy, Centronuclear, Autosomal Recessive	SPEG RYR1	3.32e-04	4	221	2	C0410204
Disease	neuromuscular disease (implicated_via_orthology)	ATAD3B ATAD3A	3.32e-04	4	221	2	DOID:440 (implicated_via_orthology)
Disease	Malignant Cystosarcoma Phyllodes	MED12 KMT2D	5.50e-04	5	221	2	C0600066
Disease	Phyllodes Tumor	MED12 KMT2D	5.50e-04	5	221	2	C0010701
Disease	neural cell adhesion molecule l1-like protein measurement	CHL1 DCBLD2	5.50e-04	5	221	2	EFO_0020595
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	HLA-DQB1 SMIM20 HCAR3 PRKAG3 NCOR2 SBF2 PCIF1 RAI1 HDLBP	6.13e-04	312	221	9	EFO_0004612, EFO_0010351
Disease	Mammary Carcinoma, Human	HOXB9 PTPRD KLHDC7A MED12 HOXB13 FLT1 ROR1 WT1 KMT2D MTHFR HADHB TP53BP2	6.50e-04	525	221	12	C4704874
Disease	Mammary Neoplasms, Human	HOXB9 PTPRD KLHDC7A MED12 HOXB13 FLT1 ROR1 WT1 KMT2D MTHFR HADHB TP53BP2	6.50e-04	525	221	12	C1257931
Disease	Mammary Neoplasms	HOXB9 PTPRD KLHDC7A MED12 HOXB13 FLT1 ROR1 WT1 KMT2D MTHFR HADHB TP53BP2	6.72e-04	527	221	12	C1458155
Disease	electrocardiography	HLA-DQB1 SPEG PTK2 HMCN2 GLUL MYO18B SFMBT1 WT1 RHOT2 SLC4A3 LRIG3 LRIG1	7.06e-04	530	221	12	EFO_0004327
Disease	Breast Carcinoma	HOXB9 PTPRD KLHDC7A MED12 HOXB13 FLT1 ROR1 WT1 KMT2D MTHFR HADHB TP53BP2	8.03e-04	538	221	12	C0678222
Disease	Bipolar Disorder	MAOB PFKL BCL9 FZD4 STK4 HCAR3 TIMELESS ROR1 EHHADH MTHFR AFG1L	1.01e-03	477	221	11	C0005586
Disease	myoclonic-atonic epilepsy (implicated_via_orthology)	ROBO3 VARS2	1.14e-03	7	221	2	DOID:0060475 (implicated_via_orthology)
Disease	contrast sensitivity measurement	NEU2 NGEF	1.14e-03	7	221	2	EFO_0005419
Disease	prostate cancer (is_marker_for)	AZGP1 ACP3 PTK2 PREX1 HOXB13 KMT2D	1.18e-03	156	221	6	DOID:10283 (is_marker_for)
Disease	lung small cell carcinoma (is_implicated_in)	PTK2 KMT2D MTHFR	1.18e-03	28	221	3	DOID:5409 (is_implicated_in)
Disease	hepatitis C (is_implicated_in)	HLA-DQB1 KIR3DL1 KIR3DS1	1.18e-03	28	221	3	DOID:1883 (is_implicated_in)
Disease	tuberculosis (is_implicated_in)	HLA-DQB1 KIR3DL1 KIR3DS1	1.18e-03	28	221	3	DOID:399 (is_implicated_in)
Disease	cognitive function measurement	BIRC6 PTK2 PTPRD PTPRF PTPRN2 SPOCK3 TNRC6A MED12L MYO18B PREX1 SFMBT1 SZT2 ABCC5 LRIG3 PHOX2A KMT2D SND1 ZNF335 LTBP1 PRLR MYBPC2 AFG1L	1.20e-03	1434	221	22	EFO_0008354
Disease	peptide measurement	ABL2 SMIM20 GLUL FLT1 PRLR	1.40e-03	109	221	5	EFO_0010520
Disease	blood viscosity	PTPRD PTPRF PNPLA5	1.60e-03	31	221	3	EFO_0004301
Disease	Mood Disorders	MAOB PFKL GLUL TIMELESS FOSB MTHFR	1.72e-03	168	221	6	C0525045
Disease	uveitis	ERAP1 TNRC18	1.94e-03	9	221	2	EFO_1001231
Disease	white matter hyperintensity measurement	PTK2 PTPRD KLHL21 CHD6 ARHGAP35 EPN2 NCOR2 SBF2	2.09e-03	302	221	8	EFO_0005665
Disease	endometrial carcinoma (is_marker_for)	ERAP1 PTK2 NCOR2	2.09e-03	34	221	3	DOID:2871 (is_marker_for)
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	HLA-DQB1 ACP2 HCAR3 PRKAG3 NCOR2 ZNF335 PCIF1	2.25e-03	239	221	7	EFO_0008317, EFO_0020945
Disease	basophil percentage of leukocytes	RYR1 PRAM1 ZNF469 ABCC5 EHHADH EIF4G3 IL3RA	2.47e-03	243	221	7	EFO_0007992
Disease	Prostatic Neoplasms	AZGP1 HOXB9 CHD6 MGA CX3CL1 MED12 HOXB13 RNF31 KMT2D ATAD3A EHHADH MTHFR	2.50e-03	616	221	12	C0033578
Disease	Malignant neoplasm of prostate	AZGP1 HOXB9 CHD6 MGA CX3CL1 MED12 HOXB13 RNF31 KMT2D ATAD3A EHHADH MTHFR	2.50e-03	616	221	12	C0376358
Disease	hepatitis B (is_implicated_in)	HLA-DQB1 KIR3DS1 MTHFR	2.67e-03	37	221	3	DOID:2043 (is_implicated_in)
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	HLA-DQB1 HCAR3 PRKAG3 NCOR2 SBF2 PCIF1 RAI1 HDLBP	2.70e-03	315	221	8	EFO_0004612, EFO_0008591
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	HLA-DQB1 HCAR3 PRKAG3 NCOR2 SBF2 PCIF1 RAI1 HDLBP	2.70e-03	315	221	8	EFO_0004574, EFO_0004612
Disease	phosphatidylcholine 32:0 measurement	PTPRD ZC3HC1	2.94e-03	11	221	2	EFO_0010372
Disease	human immunodeficiency virus infectious disease (is_implicated_in)	HLA-DQB1 KIR3DL1 KIR3DS1	3.11e-03	39	221	3	DOID:526 (is_implicated_in)
Disease	Alzheimer's disease (is_implicated_in)	MAOB GLUL RCAN1 WT1 APBB2	3.23e-03	132	221	5	DOID:10652 (is_implicated_in)
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	WT1 KIF7	3.51e-03	12	221	2	DOID:3827 (implicated_via_orthology)
Disease	Gastrointestinal Diseases	MTHFR GAST	3.51e-03	12	221	2	C0017178
Disease	Huntington Disease, Late Onset	MAOB RCAN1	3.51e-03	12	221	2	C0393574
Disease	Functional Gastrointestinal Disorders	MTHFR GAST	3.51e-03	12	221	2	C0559031
Disease	Cholera Infantum	MTHFR GAST	3.51e-03	12	221	2	C1565321
Disease	Akinetic-Rigid Variant of Huntington Disease	MAOB RCAN1	3.51e-03	12	221	2	C0751207
Disease	Juvenile Huntington Disease	MAOB RCAN1	3.51e-03	12	221	2	C0751208
Disease	testosterone measurement	PTCRA BIRC6 PTPRF MED12 STX8 FMO3 POLR1A MLX ZNF316 ZC3HC1 VARS2 CHAMP1 PRKAG3 NCOR2 SLC2A4RG HMCN1 SBF2 PRLR RAI1	3.54e-03	1275	221	19	EFO_0004908
Disease	lipid measurement, high density lipoprotein cholesterol measurement	HLA-DQB1 HCAR3 PRKAG3 NCOR2 SBF2 PCIF1 RAI1 HDLBP	3.58e-03	330	221	8	EFO_0004529, EFO_0004612
Disease	liver cirrhosis (is_implicated_in)	HLA-DQB1 KIR3DS1 MTHFR	4.10e-03	43	221	3	DOID:5082 (is_implicated_in)
Disease	Fulminant Hepatic Failure with Cerebral Edema	MAOB GLUL	4.13e-03	13	221	2	C0751197
Disease	Hepatic Stupor	MAOB GLUL	4.13e-03	13	221	2	C0751198
Disease	Hepatic Encephalopathy	MAOB GLUL	4.13e-03	13	221	2	C0019151
Disease	Hepatic Coma	MAOB GLUL	4.13e-03	13	221	2	C0019147
Disease	Charcot-Marie-Tooth disease type 4	SBF1 SBF2	4.13e-03	13	221	2	cv:C4082197
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	SMIM20 HCAR3 PRKAG3 NCOR2 PCIF1 RAI1	4.71e-03	206	221	6	EFO_0004612, EFO_0020947
Disease	nephroblastoma (is_implicated_in)	WT1 MTHFR	4.79e-03	14	221	2	DOID:2154 (is_implicated_in)
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	SMIM20 BIRC6 HCAR3 PRKAG3 NCOR2 SBF2 PCIF1	4.95e-03	276	221	7	EFO_0004612, EFO_0020943
Disease	cleft lip (is_implicated_in)	KIF7 MTHFR	5.50e-03	15	221	2	DOID:9296 (is_implicated_in)
Disease	Lymphoma, Follicular, Grade 2	KMT2D MTHFR	5.50e-03	15	221	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	KMT2D MTHFR	5.50e-03	15	221	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	KMT2D MTHFR	5.50e-03	15	221	2	C1956130
Disease	Lymphoma, Large-Cell, Follicular	KMT2D MTHFR	5.50e-03	15	221	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	KMT2D MTHFR	5.50e-03	15	221	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	KMT2D MTHFR	5.50e-03	15	221	2	C0079758
Disease	Autosomal Recessive Centronuclear Myopathy	SPEG RYR1	5.50e-03	15	221	2	C3645536
Disease	lipid metabolism disorder (implicated_via_orthology)	MTHFR HADHB	5.50e-03	15	221	2	DOID:3146 (implicated_via_orthology)
Disease	cognitive function measurement, self reported educational attainment	BIRC6 PTPRF PTPRN2 TNRC6A PREX1 SFMBT1 SND1 AFG1L	5.53e-03	355	221	8	EFO_0004784, EFO_0008354
Disease	Male sterility	KMT2D MTHFR DROSHA	5.59e-03	48	221	3	C0917731
Disease	Male infertility	KMT2D MTHFR DROSHA	5.59e-03	48	221	3	C0021364
Disease	Subfertility, Male	KMT2D MTHFR DROSHA	5.59e-03	48	221	3	C0848676
Disease	obesity (implicated_via_orthology)	STK4 GLUL MED12L MED12 PNPLA5 PLIN3	5.78e-03	215	221	6	DOID:9970 (implicated_via_orthology)
Disease	T-Cell Lymphoma	MGA KMT2D	6.25e-03	16	221	2	C0079772
Disease	preeclampsia, hypertension, pregnancy-induced	PREX1 MTHFR	6.25e-03	16	221	2	EFO_0000668, MONDO_0024664
Disease	sickle cell anemia (is_implicated_in)	HLA-DQB1 MTHFR	6.25e-03	16	221	2	DOID:10923 (is_implicated_in)
Disease	diabetic retinopathy (is_implicated_in)	HLA-DQB1 FLT1 MTHFR	6.27e-03	50	221	3	DOID:8947 (is_implicated_in)
Disease	high altitude adaptation	HLA-DQB1 MTHFR	7.05e-03	17	221	2	EFO_0009105
Disease	Kuhnt-Junius degeneration (is_implicated_in)	FLT1 MTHFR	7.05e-03	17	221	2	DOID:10873 (is_implicated_in)
Disease	Huntington Disease	MAOB RCAN1	7.05e-03	17	221	2	C0020179
Disease	Narcolepsy	HLA-DQB1 EIF3G	7.05e-03	17	221	2	C0027404

Protein segments in the cluster

Peptide	Gene	Start	Entry
PKNDAPNRFWASVEP	TADA3	146	O75528
RFGDLISKPPAWDPE	SLC4A3	46	P48751
DWRGPPNSPDLKLSD	ARHGEF18	941	Q6ZSZ5
NWKKFGNSEFDPPGP	EIF3G	101	O75821
WSDHSFQTDPDLPPG	APBB2	281	Q92870
FQTDPDLPPGWKRVS	APBB2	286	Q92870
PDSEKWNSVFPKPGT	BIRC6	701	Q9NR09
VKGSPAWEPPANDTR	CSPG5	46	O95196
EDGEQPGWPSPAKAA	ABL2	906	P42684
PDGPPELFDAWLSQF	BSDC1	136	Q9NW68
LSPQAPFPKLGWDDE	PRKAG3	161	Q9UGI9
TGWPEEPAPETQFKR	DUSP8	571	Q13202
PAPKDKWSNFDPTGL	ATAD3A	41	Q9NVI7
AALAPLATAPGKPFW	AFG1L	31	Q8WV93
IKFPEWNDLPPGTSQ	DEPDC1B	126	Q8WUY9
SIDWGTAFPKPLLTP	DPH1	351	Q9BZG8
PALPPVWDVSASAKG	DLX6	131	P56179
ARPVAEPNPGFWSQL	DUSP28	136	Q4G0W2
LPPLEKFNNWGGSLS	HADHB	411	P55084
PDWSPSNADLFPSQG	TP53BP2	411	Q13625
PTFKASPSWVDPEGE	ALPK1	776	Q96QP1
FTIWDGGSKNPAEPQ	NWD1	946	Q149M9
DPIIPFSDGPIISKW	RC3H2	891	Q9HBD1
ASPPVGWKQVEDATP	RCAN1	166	P53805
DSVAKSAWPRPGEPE	RAI1	651	Q7Z5J4
PLPGSELTKEPFRWD	INTS6L	151	Q5JSJ4
PLPGSELTKEPFRWD	INTS6	151	Q9UL03
LGPAPGTESPQAEFW	ITPKC	76	Q96DU7
FVLTSEAAGWPKPDP	HDHD3	156	Q9BSH5
HLGTSFKDPDPWTPA	P3H3	396	Q8IVL6
FTSWPDQKTPDRAPP	PTPN5	456	P54829
QKWPSPLGDSEDPSS	PTPRN2	286	Q92932
PGKNGQFPIPSITWE	LILRA2	76	Q8N149
ASPEDPWVKASPVGA	MLX	6	Q9UH92
DDTWDPGSPVRKPAL	ANKRD34B	221	A5PLL1
GREIPSDAPWKAPLA	MAOB	126	P27338
KTEEFPSFIPWAPSA	OVOS1	966	Q6IE37
ATPTPFGKDQDWPAL	RAB3GAP2	1241	Q9H2M9
AAEAQKLPGDPPCWT	NCOR2	1036	Q9Y618
AEEPDPKGIPEFWFT	NAP1L4	151	Q99733
PAGDPDTWKTDQRPT	FAM189A1	451	O60320
WLEPLSGAVSFPSFP	HOXC9	96	P31274
APELQPNAVTWGIFP	MTHFR	551	P42898
DVAPPGLDSPIWFSA	PTCRA	51	Q6ISU1
PSENFIWGPPRKEQS	OGFRL1	306	Q5TC84
IGAKPNIPWLFLTDP	FMO3	441	P31513
VSPWDLFEGQKNPAP	MED12L	1671	Q86YW9
AAWKNLPATPETFAP	MAGEL2	771	Q9UJ55
ATGNPPPRITWFKGD	LRIG1	716	Q96JA1
GNPEPTFSWTKDGNP	CHL1	61	O00533
PFWNLTGTNPASPDA	MGA	761	Q8IWI9
APWAGAATPLLPTEN	IRAK2	546	O43187
PWESQDGKGLSPQPA	GPR179	2076	Q6PRD1
FPQKDWDDTPFPQGI	SBF2	31	Q86WG5
APQIAWQKDGGTDFP	LRIG3	631	Q6UXM1
GGSPPPKLNWTKDDS	LRIG3	721	Q6UXM1
PEGAAFSWLPNPERS	MYO19	256	Q96H55
FFKNTPWPEAEAIAP	EIF3L	106	Q9Y262
PPANWLRESAKLGPA	EDRF1	76	Q3B7T1
NPYEPELAPWAADKG	SYK	321	P43405
LPSSGPAAQKAEPWG	EPN2	341	O95208
LASGVPPPDVSWFKG	HMCN2	1916	Q8NDA2
QDAEGPPAKPWTSLL	KATNIP	371	O60303
GSPTVWPDAFPKVLK	ASB18	356	Q6ZVZ8
QLPGAGDSSFPSWLK	DOP1B	781	Q9Y3R5
VPFPLDNNKSKPGGW	IL17RB	276	Q9NRM6
NPPLKEWQSLAGSPS	EHHADH	706	Q08426
QDKPFLSAWPSAVVP	KIR3DL1	26	P43629
KARPSAWEPAAGNSP	MICALL2	281	Q8IY33
EASPKRSDGTPFPWN	ERAP1	36	Q9NZ08
VWDGDFPIDKPPSFR	PLXNA3	766	P51805
PGAASSWGPPEQAAK	LTBP1	236	Q14766
GTPDKNPWLAFPLGF	OR51H1	21	Q8NH63
LASGADWLFIPEAPP	PFKL	221	P17858
EAGLPWNFGPLSKPR	KIF7	1311	Q2M1P5
EWSNRTTPKPEDAGP	NFX1	191	Q12986
GPPSEPVDWNFAQKE	KIF1C	616	O43896
SPWDLFEGLKPSAPL	MED12	1686	Q93074
WSKELPFQPPEGSIS	LRGUK	751	Q96M69
GSKPKFDWVSAPDGP	GGN	346	Q86UU5
QSDFLTPPVGGAPWA	MAN1B1	16	Q9UKM7
PWRYAPDKQAPGSDS	SMPD4	446	Q9NXE4
CEVSGFPPPDLSWLK	HMCN1	2986	Q96RW7
FPEKDWEDNPFPQGI	SBF1	31	O95248
PQGKEPLAVPWEGSS	NUTM1	671	Q86Y26
LSWDPPVKPNGAIIS	PTPRQ	1211	Q9UMZ3
PKSIPDYWDSSALPD	PARP12	481	Q9H0J9
LPGSAPAKEDGFSWL	FOSB	241	P53539
SFQPKAPVFGASWAP	HOXB9	51	P17482
PAPEAWSEPVLLAKG	NEU2	316	Q9Y3R4
NESDKAPWPLSLPGC	ACP2	331	P11117
AALFPPEGVSIWNPI	ACP3	121	P15309
WAIEKNLTPVPGAPS	FBXO17	131	Q96EF6
KAPSPDWPQEGEVTF	ABCC5	1181	O15440
WTNFAKTGDPNKPVP	NLGN3	561	Q9NZ94
ASWKPRSQQPDAPLG	GAST	21	P01350
GFAWPESLNCSKFPP	FZD4	136	Q9ULV1
AVTPLGPPDAEYWNS	HLA-DQB1	81	P01920
NGPPFFSPLQSLWEE	GSN-AS1	26	Q9NRJ2
SWAEGSVKAPAPIPE	FCAMR	251	Q8WWV6
TGDPKPKIFWLLPSN	IGSF10	2166	Q6WRI0
FPENSGKPWAGAENL	IL3RA	96	P26951
KPIFWIQAETPALPG	IGSF1	131	Q8N6C5
DTFPKPWLFAEPSSV	IGSF1	966	Q8N6C5
APWFDPAIFTIGKPV	GMPS	86	P49915
VDCGQLPPWSFAPKT	KLHL21	451	Q9UJP4
RGAADVSSPEAWPPK	BNIP5	311	P0C671
NDPGFAKWAPTPERL	PCIF1	646	Q9H4Z3
INPFWGGSALLKPPE	CCDC63	481	Q8NA47
KEPVPWEFPSSLAFS	DNAH17	401	Q9UFH2
FLPWTDKVPSFELDP	DNAH17	2406	Q9UFH2
AAQDGSDPDKSPWPV	CHD6	1376	Q8TD26
AKGAPPPTVTWALDD	DSCAML1	431	Q8TD84
KPSGSPDLWKLSPDQ	CHAMP1	441	Q96JM3
FKITWDPPKDNGGAT	FNDC3A	581	Q9Y2H6
SWPDDVPKIPDGRNF	BCL9	591	O00512
VVKGPGAPDASFPTW	CRYBG2	531	Q8N1P7
AASFQAWGPPSPELL	CTSF	26	Q9UBX1
EKEPASSPWASGEKP	DIDO1	1611	Q9BTC0
EIGRDTFWPDSEPKP	GLI4	66	P10075
RDFGLWTTPAGPKDP	MAP6D1	71	Q9H9H5
EKLLPAFNTPTGIPW	MAN1A2	296	O60476
VADFAVQPAVKPWAP	CCDC32	56	Q9BV29
AGGEPSPWQDSKPRE	KLHDC7A	181	Q5VTJ3
ARLKKPGPPWAAFAT	DCBLD2	331	Q96PD2
ASFLNGAKGDPEPWP	FIGNL2	86	A6NMB9
EGVLEFLPKSLFPPW	CCDC168	5911	Q8NDH2
GEQNPPGPFWKAAFA	HOXB13	186	Q92826
WFSKGLPQFEPVPLE	RYR1	1236	P21817
GDGVTFPFKPESWKP	EIF4G3	601	O43432
FPFKPESWKPTDTEG	EIF4G3	606	O43432
AGSPERAPVQNSPWK	INAVA	311	Q3KP66
QKSSAQGPIPWFLPE	PPEF2	336	O14830
NPDPEISWFKDFLPV	PTPRF	161	P10586
GNPDPEITWFKDFLP	PTPRD	151	P23468
PAFPPQAGALWDEAL	NR4A3	146	Q92570
EPLAKPNRPDTSFSW	FER1L6	1791	Q2WGJ9
ATFDPKPIPGNWNGA	GLUL	236	P15104
AFPSAKDPTWEDRFP	RETSAT	441	Q6NUM9
LFPFSALGWPQETPD	VARS2	591	Q5ST30
GPPQEETKPKFGDWS	SZT2	1156	Q5T011
ETKPKFGDWSGAPSL	SZT2	1161	Q5T011
DWNLKGPLFEDSPPC	DROSHA	661	Q9NRR4
SLWTSKPPPLFHEGA	PWWP2A	256	Q96N64
AANQEDKSPTWGEPP	TNRC6C	561	Q9HCJ0
WVKETPRSVPGFNPD	POLR1A	716	O95602
SPNDFALWKASKPGE	CARS1	316	P49589
FDPDGAPLSELSWPS	AATK	16	Q6ZMQ8
SLFSVFPAAPWGPEL	RHOT2	331	Q8IXI1
IFRDAFWPNGKLAPP	SNX25	741	Q9H3E2
PTSWALFELPGPSQA	PLEKHG3	781	A1L390
FLSGKWTIPPDPRNE	SAMD9L	1231	Q8IVG5
VSKEPPAPADGNWDA	PNPLA5	266	Q7Z6Z6
KPKIQAPGETFPTDW	FAM178B	96	Q8IXR5
VSWDSGGSDEAPPKP	PTK2	701	Q05397
APEALIANSGEPWSP	HCAR3	341	P49019
QDKPFLSAWPSAVVP	KIR3DS1	26	Q14943
WLVGPFAPGITEKAP	PLIN3	416	O60664
NGATPEEWPALADSP	NGEF	136	Q8N5V2
SEPKSGAFPRKLWQP	PRAM1	181	Q96QH2
KLWQPEAGEATPRSP	PRAM1	191	Q96QH2
AAPSWKCLPAAEGDP	PREX1	1026	Q8TCU6
DVQPPGLKVWSDPFG	SMIM20	51	Q8N5G0
KDTPDEPWAFPAREF	SND1	71	Q7KZF4
GTEAFDSWEKPPLPV	SCARB2	46	Q14108
PWNVPDVKPFSQTPF	TEAD2	171	Q15562
ASPKAQWPQSEDEGP	WIZ	1016	O95785
WPAAGFELPAFDPRT	PNKP	331	Q96T60
ETSPFITPGKPWEEA	ARHGAP35	441	Q9NRY4
WDPGTSALPAPGIKQ	RHBDL1	16	O75783
TNPPSFSGPWEDKEF	SLC28A2	626	O43868
EKGHIEPSFSPWNSP	ERVK-9	981	P63128
PPPERKQSFLWEGSA	SLX4	521	Q8IY92
SVPLFPFASQGANPW	SMCR8	31	Q8TEV9
GEVWGKSPEPEFPSL	APOL5	36	Q9BWW9
PAPKDKWSNFDPTGL	ATAD3B	41	Q5T9A4
PWQSLDPFDSLESKP	NCAPH2	316	Q6IBW4
PDNAIPIKSWFSDPS	CTDNEP1	196	O95476
WEDAPSKGPSIHFLP	C12orf71	41	A8MTZ7
VWGPSPKFPQLDSDE	NKAPL	136	Q5M9Q1
LDGPAQEPQSAPWLS	RHBDD3	306	Q9Y3P4
VSGNPPPTIRWFKND	ROR1	81	Q01973
PTPSWDGPDKQSLVR	RNF31	631	Q96EP0
TEPDASAPAEPGWKA	ZC3HC1	446	Q86WB0
FPPFGTPEWDQKDDA	TMEM45B	196	Q96B21
SEPKAPWPKATDGDL	TNRC18	2511	O15417
PWPKATDGDLAQEPG	TNRC18	2516	O15417
PPASGQETFWRIPAK	TIMELESS	1071	Q9UNS1
AWPGSPAVKNESKFP	ZNF503-AS2	121	A6NEH8
PNTGVPVAQPAKSWD	TTLL8	706	A6PVC2
APKEAGPSKEASLWP	ZBTB21	896	Q9ULJ3
PLFDAAFPTPQWGIV	ZNF865	136	P0CJ78
LEQPKSERGAPWGTP	SPEG	436	Q15772
AAFSPEPGLEPWKEA	SLC2A4RG	126	Q9NR83
DPPLCAWEANKFLTP	SMRP1	31	Q8NCR6
LKAWQPAESGPGPFS	PHOX2A	251	O14813
KGNPPPAIFWQKEGS	ROBO3	371	Q96MS0
DSLPSDPVQPQYGAW	SLC12A9	571	Q9BXP2
DPPAVKWGSVSNPLF	EXT2	431	Q93063
PWLLPQEKTPFGSAK	PRLR	491	P16471
GFSRAAALDPAWPEP	TTC5	246	Q8N0Z6
DVQLPPWADGDPRKF	WDFY4	2721	Q6ZS81
AAQWAPVLDFAPPGA	WT1	31	P19544
PDVDSTKSPWEPDGL	MYCBPAP	701	Q8TBZ2
LFDEATKADPLWGGP	TLCD4	71	Q96MV1
AKRGAPNPWLFEEPE	STX8	116	Q9UNK0
GYIPPSKEESDWPAS	PHF23	46	Q9BUL5
WAGQGKASPPSLEQP	WDR46	426	O15213
RTWSPGKPFDQALDP	SPOCK3	71	Q9BQ16
EEPLGSDPFSWKLPS	MYO18B	2416	Q8IUG5
GPASAKAEPPQKSNW	ZC2HC1C	441	Q53FD0
FQGDGAPPLDATWPF	ZNF469	1781	Q96JG9
CLGPKSDPDLETPWA	WDR59	706	Q6PJI9
AQPPKNAAWDPTTGA	ZNF688	151	P0C7X2
EFNKEIPAWVPFDPA	AZGP1	146	P25311
WKPETPQDSSGLAPF	WASHC2A	931	Q641Q2
EPGANLLSPWAFPAA	ZNF316	321	A6NFI3
GSPFGLEEPQWVPDK	ZFYVE21	31	Q9BQ24
LEAVDPWSPFGISPA	SFMBT1	281	Q9UHJ3
PPTFRKPELWSDNFT	STK4	241	Q13043
FGKSVPGPLKNSSDW	STK4	411	Q13043
LLAASGPTWDQVPPF	PLBD2	546	Q8NHP8
PSFGAQVAPKTLPWG	HDLBP	1251	Q00341
KADVVFLSPPWGGPD	TGS1	756	Q96RS0
DATFEEWFPQGRPPK	VPS72	271	Q15906
AFPSPEVVWLKDGLP	FLT1	361	P17948
KPSLVSDLPWEGAAP	SNTB2	206	Q13425
SDLPWEGAAPQSPSF	SNTB2	211	Q13425
SFPSPDALASGAKWP	ZNF335	946	Q9H4Z2
KDWFVLPFLPSPDTN	WDR91	126	A4D1P6
KEAWPSAPGSDPELA	TNRC6A	236	Q8NDV7
DEFWKNPPVLAPTST	VPS37A	121	Q8NEZ2
APHQPGPSLWAEAKT	CX3CL1	201	P78423
DQSPWKVFSGGPPVR	FAM53A	46	Q6NSI3
ADTLFSKGLGPWDPP	KMT2D	4366	O14686
SKGLGPWDPPDNLAE	KMT2D	4371	O14686
EGKSPDTGPDWLKQF	KMT2D	4846	O14686
PQISWQKDGGTDFPA	LRIG2	631	O94898
PVWEPDDPSLGDKAA	SLC8A2	56	Q9UPR5
PPASKFWSLGEKPQI	MXRA5	1841	Q9NR99
EPPPVATWLKGDEVF	MYBPC2	571	Q14324
NPPPFKSVWSRLDGQ	NECTIN3	296	Q9NQS3